Document is current

Any future updates will be listed below

Meta-analysis of published efficacy and safety data for docetaxel in second-line treatment of patients with advanced non-small-cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s00280-015-2957-7

Published Online: 2016-01-12

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark